Prescription drug · ANDA
Metoprolol Succinate NDC 27808-305
Metoprolol succinate 200 mg/1 · Tablet, Extended release · Oral · Cranbury Pharmaceuticals, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 27808-305-01 | 27808030501 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (27808-305-01)Marketed from Jun 1, 2025 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Metoprolol Succinate
- Generic name (nonproprietary)
- metoprolol succinate
- Active ingredients
- Metoprolol succinate — 200 mg/1
- Dosage form
- Tablet, Extended release
- Route
- Oral
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 207206
- Marketing start
- Listing expires
- Other FDA classes
- Adrenergic beta-Antagonists (Mechanism)
- Identifiers
- Product ID 27808-305_a7845f10-48d0-478b-a760-c1fd208c09b9SPL ID a7845f10-48d0-478b-a760-c1fd208c09b9SPL set ID 8b8cae90-e02a-4a99-81ff-37629c9a4243RxCUI 866412, 866419, 866427, 866436UNII TH25PD4CCB
- Pharmacologic class
- beta-Adrenergic Blocker
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N427808030501followed by a unit qualifier and the quantityPackage 27808-0305-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Metoprolol succinate extended-release tablets, are a beta-adrenergic blocker indicated for the treatment of: Hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. ( 1.1 ) Angina Pectoris. ( 1.2 ) Heart Failure, to reduce the risk of cardiovascular mortality and heart failure hospitalizations in patients with heart failure. ( 1.3 ) 1.1 Hypertension Metoprolol succinate extended-release tablets are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myoc…
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 207206
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Metoprolol Succinate | Metoprolol tartrate 50 mg/1 | Tablet, Extended releaseOral | PD-Rx Pharmaceuticals, Inc. | 72789-497 |
| Metoprolol Succinate | Metoprolol succinate 25 mg/1 | Tablet, Extended releaseOral | Cranbury Pharmaceuticals, LLC | 27808-302 |
| Metoprolol Succinate | Metoprolol succinate 50 mg/1 | Tablet, Extended releaseOral | Cranbury Pharmaceuticals, LLC | 27808-303 |
| Metoprolol Succinate | Metoprolol succinate 100 mg/1 | Tablet, Extended releaseOral | Cranbury Pharmaceuticals, LLC | 27808-304 |
| Metoprolol Succinate | Metoprolol tartrate 100 mg/1 | Tablet, Extended releaseOral | Preferred Pharmaceuticals Inc | 68788-8448 |
| Metoprolol Succinate | Metoprolol tartrate 100 mg/1 | Tablet, Extended releaseOral | REMEDYREPACK INC. | 70518-4190 |
| Metoprolol Succinate | Metoprolol tartrate 25 mg/1 | Tablet, Extended releaseOral | Oryza Pharmaceuticals, Inc | 72516-030 |
| Metoprolol Succinate | Metoprolol tartrate 50 mg/1 | Tablet, Extended releaseOral | Oryza Pharmaceuticals, Inc | 72516-031 |
| Metoprolol Succinate | Metoprolol tartrate 100 mg/1 | Tablet, Extended releaseOral | Oryza Pharmaceuticals, Inc | 72516-032 |
| Metoprolol Succinate | Metoprolol tartrate 200 mg/1 | Tablet, Extended releaseOral | Oryza Pharmaceuticals, Inc | 72516-033 |
| Metoprolol Succinate | Metoprolol tartrate 50 mg/1 | Tablet, Extended releaseOral | A-S Medication Solutions | 50090-6448 |
| Metoprolol Succinate | Metoprolol tartrate 25 mg/1 | Tablet, Extended releaseOral | A-S Medication Solutions | 50090-6489 |
| Metoprolol Succinate | Metoprolol tartrate 50 mg/1 | Tablet, Extended releaseOral | NuCare Pharmaceuticals, Inc. | 68071-3943 |
| Metoprolol Succinate | Metoprolol tartrate 25 mg/1 | Tablet, Extended releaseOral | A-S Medication Solutions | 50090-6488 |
| Metoprolol Succinate | Metoprolol tartrate 50 mg/1 | Tablet, Extended releaseOral | NuCare Pharmaceuticals, Inc. | 68071-3965 |
| Metoprolol Succinate | Metoprolol tartrate 50 mg/1 | Tablet, Extended releaseOral | Proficient Rx LP | 82804-014 |
| Metoprolol Succinate | Metoprolol tartrate 25 mg/1 | Tablet, Extended releaseOral | REMEDYREPACK INC. | 70518-4090 |